A Study Of Genomic Basis Of Clonal Expansion In Paroxysmal Nocturnal Hemoglobinuria

Overview

About this study

The purpose of this study is to Define genomic landscape in PNH

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 and above
Diagnosis of PNH
Willing to have blood collection
Ability to provide informed consent

Exclusion Criteria:

Inability to provide informed consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 03/02/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator David Dingli, M.D., Ph.D.	Open for enrollment	Contact information: Sarah Aug 5075381301 aug.sarah@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Dingli, M.D., Ph.D.

Open for enrollment

Contact information:

Sarah Aug

5075381301

aug.sarah@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials